CN101569697B - Chinese traditional medicine for treating postpartum retained afterbirth of female animals - Google Patents
Chinese traditional medicine for treating postpartum retained afterbirth of female animals Download PDFInfo
- Publication number
- CN101569697B CN101569697B CN2009100747254A CN200910074725A CN101569697B CN 101569697 B CN101569697 B CN 101569697B CN 2009100747254 A CN2009100747254 A CN 2009100747254A CN 200910074725 A CN200910074725 A CN 200910074725A CN 101569697 B CN101569697 B CN 101569697B
- Authority
- CN
- China
- Prior art keywords
- medicine
- female animal
- chinese traditional
- radix
- retained afterbirth
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a Chinese traditional medicine for treating postpartum retained afterbirth of a female animal, which belongs to the technical field of medicines and is used for treating postpartum retained afterbirth with simplicity, speediness and low cost. The Chinese traditional medicine is characterized in comprising bulk drugs by the following parts by weight: 5 to 20 of charred schizonepeta, 5 to 20 of chuanxiong rhizome, 5 to 20 of Chinese angelica root, 5 to 20 of two tooth achyranthes root and 5 to 20 of stir-fried cat-tail pollen. The medicine in the invention is based on theChinese traditional veterinary theory, treats postpartum retained afterbirth of the female animal on the principles of total concept and diagnosis and treatment based on an overall analysis of the illness and the patient's condition, and is prepared from pure Chinese traditional medicines by repeating grope and practice. The invention has the following characteristics: 1. the medicine takes effect rapidly and has good curative effect, and common diseases can be cured once; 2. the medicine is simple to use and can be directly drenched, thereby raisers can operate by themselves; 3. the medicineis safe to use and has no toxic or side effect on the female animal; and 4. the cost is low, the medicine is easy to accept by raisers.
Description
Technical field
The present invention relates to a kind of Chinese medicine, particularly treat the Chinese medicine of female animal placenta retention in puerperal, belong to medical technical field.
Background technology
Domestic animal is about to afterbirth (the attached film of fetus) and discharges in puerperal certain hour.The normal time that various domestic animal afterbirths are discharged is: horse 1-1.5h, pig 1h, sheep 4h, cattle 12h.If female animal puerperal, afterbirth can not in time be discharged in normal time, claims placenta retention.The various domestic animals of placenta retention all can be taken place, and attach most importance to milch cow especially, can be up to 25-40% in some cattle farm.Placenta retention mostly is the puerperal inertia of uterus and causes that other factorses such as fetal placenta and placenta materna adhesion are also arranged.Get to the bottom of sb.'s illness, with lack move, become thin, overfertilization, shortage calcium, selenium, vitamin or other disease be relevant, female animal age, parity and childbirth are also influential to the generation of this disease season in addition.Placenta retention often causes endometritis, causes female animal infertile; After the afterbirth corruption, produce some poisonous gases, liquid, after being absorbed by body, influence milk yield; Serious also easily cause septicemia and cause female animal death.At present, the Therapeutic Method for placenta retention comprises: adopt to promote uterotonic medicine injection to promote fetal placenta and placenta materna side from, injection of antibiotic and operative treatment.Above-mentioned Therapeutic Method need be executed by professional veterinary usually and control, and treatment means is difficult for grasping, and medical expense is also higher, causes the certain economic burden for the family-raise family.
Summary of the invention
Technical problem to be solved by this invention is: provide that a kind of medication is easy, the Chinese medicine of the treatment female animal placenta retention in puerperal of good effect, instant effect.
Alleged problem of the present invention is solved by following technical scheme:
A kind of Chinese medicine for the treatment of female animal placenta retention in puerperal, its special feature is: comprise following bulk drugs in the composition: Herba Schizonepetae charcoal 5-20, Rhizoma Chuanxiong 5-20, Radix Angelicae Sinensis 5-20, Radix Achyranthis Bidentatae 5-20, Pollen Tyjphae (parched) 5-20.
The Chinese medicine of above-mentioned treatment female animal placenta retention in puerperal comprises following bulk drugs in the described medicament: Oletum Trogopterori 5-20, Cortex Moutan 5-30, Flos Carthami 5-30.
The Chinese medicine of above-mentioned treatment female animal placenta retention in puerperal comprises following bulk drugs in the described medicament: Pericarpium Citri Reticulatae 5-20, Radix Aconiti Lateralis Preparata 5-20.
Medicament of the present invention with organic conception and determination of treatment based on pathogenesis obtained through differentiation of symptoms and signs principle treatment female animal placenta retention in puerperal, through groping practice repeatedly, obtains one group of prescription of being made up of pure Chinese medicine based on Chinese medical theory.This medicine set of guidelines does not freely cause this sick cause of disease to female animal because of QI-blood circulation, determines the relation between flavour of a drug, dosage and the compatibility, and all medicines share in the side, play the effect of blood circulation promoting and blood stasis dispelling, vigorate qi and replenish the blood, dispelling cold by warming the meridian pain relieving altogether.Compare with present this sick method of treatment commonly used, the characteristics of medicament of the present invention are as follows: 1. instant effect, good effect, and general disease medication is once promptly good; 2 application methods are simple, directly gavage to get final product, and the raiser can be from line operate; 3. drug safety does not produce any toxic side effects to female animal; 4. medical expense is low, is easily cultured in every family and accepts.
The specific embodiment
The present invention thinks that from the traditional Chinese medical science veterinary viewpoint female animal suffers from this sick main diseases because of being that QI-blood circulation is not smooth, a little less than the uterus energy, and can not make afterbirth normally discharge.Cause the not smooth factor of QI-blood circulation to have: 1. the deficiency of vital energy: the pregnancy period feeds inappropriate, malnutrition, and body constitution is thin and weak; Or stages of labor is long, excessively exerts duty, and the QI and blood loss is too much, or or fetus excessive, polyhydramnios etc. all can make its asystole, unable discharge afterbirth forms trouble.2. coagulation of QI-blood, during production nursing improper, experience the cold-evil, the cold coagulation stasis, blood road obturation can not discharge retained afterbirth, 3. miscarriage, premature labor, difficult labour, vulneratio uteri.
Radix Angelicae Sinensis promoting blood circulation and stopping pain, tonifying blood and regulating menstruation in the prescription, promoting tissue regeneration by removing blood stasis are principal agent, and the pharmacological action of Radix Angelicae Sinensis has excitation to the uterus, and uterine contraction is strengthened.Herba Schizonepetae charcoal, the hemostasis of Pollen Tyjphae (parched) dissipating blood stasis; The Oletum Trogopterori blood circulation and channel invigorating, eliminating stasis to stop pain; Removing stasis to stop bleeding, the removing food stagnancy detoxifcation; The Rhizoma Chuanxiong blood-activating and qi-promoting, wind-expelling pain-stopping, dissipating depression of QI dampness; The Flos Carthami promoting blood circulation to restore menstrual flow, reducing swelling and alleviating pain; The Cortex Moutan clearing away heat and cooling blood, blood circulation promoting and blood stasis dispelling; The Pericarpium Citri Reticulatae regulating qi-flowing for strengthening spleen, drying dampness to eliminate phlegm, dyspepsia and intestinal stasis relieving; The Radix Aconiti Lateralis Preparata warming spleen and stomach for dispelling cold, removing damp and stopping pain, above-mentioned all medicines are adjuvant altogether, Radix Achyranthis Bidentatae blood circulation promoting and blood stasis dispelling, conducting blood to flow downwards are messenger drug.
Above-mentioned all medicines are shared, take mutually together, play the effect of blood circulation promoting and blood stasis dispelling, vigorate qi and replenish the blood, dispelling cold by warming the meridian pain relieving altogether.
Several embodiment below are provided:
Embodiment 1: take by weighing Herba Schizonepetae charcoal 50g, Rhizoma Chuanxiong 100g, Radix Angelicae Sinensis 50g, Radix Achyranthis Bidentatae 50g, Pollen Tyjphae (parched) 150g.
Embodiment 2: take by weighing Herba Schizonepetae charcoal 200g, Rhizoma Chuanxiong 150g, Radix Angelicae Sinensis 200g, Radix Achyranthis Bidentatae 200g, Pollen Tyjphae (parched) 50g.
Embodiment 3: take by weighing Herba Schizonepetae charcoal 100g, Rhizoma Chuanxiong 50g, Radix Angelicae Sinensis 150g, Radix Achyranthis Bidentatae 100g, Pollen Tyjphae (parched) 200g.
Embodiment 4: take by weighing Herba Schizonepetae charcoal 150g, Rhizoma Chuanxiong 200g, Radix Angelicae Sinensis 100g, Radix Achyranthis Bidentatae 150g, Pollen Tyjphae (parched) 100g, Oletum Trogopterori 50g, Cortex Moutan 300g, Flos Carthami 300g.
Embodiment 5: take by weighing Herba Schizonepetae charcoal 70g, Rhizoma Chuanxiong 80g, Radix Angelicae Sinensis 80g, Radix Achyranthis Bidentatae 120g, Pollen Tyjphae (parched) 100g, Oletum Trogopterori 200g, Cortex Moutan 50g, Flos Carthami 300g.
Embodiment 6: take by weighing Herba Schizonepetae charcoal 120g, Rhizoma Chuanxiong 200g, Radix Angelicae Sinensis 200g, Radix Achyranthis Bidentatae 150g, Pollen Tyjphae (parched) 100g, Oletum Trogopterori 100g, Cortex Moutan 300g, Flos Carthami 50g.
Embodiment 7: take by weighing Herba Schizonepetae charcoal 100g, Rhizoma Chuanxiong 150g, Radix Angelicae Sinensis 150g, Radix Achyranthis Bidentatae 100g, Pollen Tyjphae (parched) 150g, Oletum Trogopterori 150g, Cortex Moutan 300g, Flos Carthami 150g, Pericarpium Citri Reticulatae 50g, Radix Aconiti Lateralis Preparata 100g.
Embodiment 8: take by weighing Herba Schizonepetae charcoal 150g, Rhizoma Chuanxiong 200g, Radix Angelicae Sinensis 200g, Radix Achyranthis Bidentatae 150g, Pollen Tyjphae (parched) 200g, Oletum Trogopterori 200g, Cortex Moutan 180g, Flos Carthami 250g, Pericarpium Citri Reticulatae 150g, Radix Aconiti Lateralis Preparata 200g.
Embodiment 9: take by weighing Herba Schizonepetae charcoal 50g, Rhizoma Chuanxiong 120g, Radix Angelicae Sinensis 180g, Radix Achyranthis Bidentatae 100g, Pollen Tyjphae (parched) 150g, Oletum Trogopterori 100g, Cortex Moutan 200g, Flos Carthami 150g, Pericarpium Citri Reticulatae 200g, Radix Aconiti Lateralis Preparata 50g.
When this medicament is used for the treatment of female animal placenta retention in puerperal according to following dosage medication: cattle, horse consumption are the 100-1000g crude drug, and pig, sheep consumption are the 20-200g crude drug.Chan is broken into the end with crude drug, adds boiled water and stirs, and treats to pour into ill domestic animal is disposable behind the Wen Liang, and every day 1 time, medication can be cured for 2-3 time usually, and serious symptom person's logotype gets final product for 5 times.
Claims (3)
1. a Chinese medicine for the treatment of female animal placenta retention in puerperal is characterized in that: be made up of following bulk drugs: Herba Schizonepetae charcoal 5-20, Rhizoma Chuanxiong 5-20, Radix Angelicae Sinensis 5-20, Radix Achyranthis Bidentatae 5-20, Pollen Tyjphae (parched) 5-20.
2. a Chinese medicine for the treatment of female animal placenta retention in puerperal is characterized in that: be made up of following bulk drugs: Herba Schizonepetae charcoal 5-20, Rhizoma Chuanxiong 5-20, Radix Angelicae Sinensis 5-20, Radix Achyranthis Bidentatae 5-20, Pollen Tyjphae (parched) 5-20, Oletum Trogopterori 5-20, Cortex Moutan 5-30, Flos Carthami 5-30.
3. a Chinese medicine for the treatment of female animal placenta retention in puerperal is characterized in that: be made up of following bulk drugs: Herba Schizonepetae charcoal 5-20, Rhizoma Chuanxiong 5-20, Radix Angelicae Sinensis 5-20, Radix Achyranthis Bidentatae 5-20, Pollen Tyjphae (parched) 5-20, Oletum Trogopterori 5-20, Cortex Moutan 5-30, Flos Carthami 5-30, Pericarpium Citri Reticulatae 5-20, Radix Aconiti Lateralis Preparata 5-20.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2009100747254A CN101569697B (en) | 2009-06-12 | 2009-06-12 | Chinese traditional medicine for treating postpartum retained afterbirth of female animals |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2009100747254A CN101569697B (en) | 2009-06-12 | 2009-06-12 | Chinese traditional medicine for treating postpartum retained afterbirth of female animals |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101569697A CN101569697A (en) | 2009-11-04 |
| CN101569697B true CN101569697B (en) | 2011-10-26 |
Family
ID=41229266
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2009100747254A Expired - Fee Related CN101569697B (en) | 2009-06-12 | 2009-06-12 | Chinese traditional medicine for treating postpartum retained afterbirth of female animals |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101569697B (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102085352B (en) * | 2011-01-28 | 2012-05-23 | 浙江大学 | Traditional Chinese medicine composition for preventing and controlling intrauterine residues after medicinal abortion and application thereof |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1634362A (en) * | 2004-11-18 | 2005-07-06 | 西北农林科技大学 | Chinese patent medicine for preventing and treating postpartum cow constitutional weakness and retained afterbirth |
| CN101143177A (en) * | 2007-08-16 | 2008-03-19 | 河南花花牛奶牛育种科技有限公司 | Medicine for preventing and treating postpartum disease of cow |
| CN101391087A (en) * | 2008-10-23 | 2009-03-25 | 布焕霞 | Medicine for treating placental retention of dairy cows after delivery |
-
2009
- 2009-06-12 CN CN2009100747254A patent/CN101569697B/en not_active Expired - Fee Related
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1634362A (en) * | 2004-11-18 | 2005-07-06 | 西北农林科技大学 | Chinese patent medicine for preventing and treating postpartum cow constitutional weakness and retained afterbirth |
| CN101143177A (en) * | 2007-08-16 | 2008-03-19 | 河南花花牛奶牛育种科技有限公司 | Medicine for preventing and treating postpartum disease of cow |
| CN101391087A (en) * | 2008-10-23 | 2009-03-25 | 布焕霞 | Medicine for treating placental retention of dairy cows after delivery |
Also Published As
| Publication number | Publication date |
|---|---|
| CN101569697A (en) | 2009-11-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103585378B (en) | A Chinese medicinal composition for treating female infertility, and its preparation method | |
| CN101391087B (en) | Medicine for treating placental retention of dairy cows after delivery | |
| CN103316312B (en) | A kind of tonification clearing heat in the pericardium mixture and preparation technology thereof | |
| CN101569697B (en) | Chinese traditional medicine for treating postpartum retained afterbirth of female animals | |
| CN1879838A (en) | A Chinese medicine for treating threatened abortion | |
| CN101919969A (en) | Traditional Chinese medicine oral liquid preparation for treating hemorrhoids | |
| CN104147530A (en) | Medicine for treating ectopic pregnancy and application thereof | |
| CN102988892A (en) | Medicament for treating hysteromyoma and ovarian cysts | |
| CN103120789B (en) | Traditional Chinese medicine composition for treating migraine | |
| CN103877282A (en) | Traditional Chinese medicine preparation for treating salpinx obstructive infertility caused by accumulation and stasis of damp-heat | |
| CN103893480A (en) | Traditional Chinese medicine preparation for treating kidney deficiency and blood stasis type oviduct obstructive infertility | |
| CN102078516B (en) | Traditional Chinese medicine for treating bone injury | |
| CN104224985B (en) | A kind of Chinese medicine for treating postpartum lochiorrhea | |
| CN104606368A (en) | Traditional Chinese medicine composition for treating threatened abortion in first trimester of pregnancy | |
| CN104667026A (en) | Traditional Chinese medicine composition for treating gastrointestinal heat accumulation type constipation | |
| CN104117018A (en) | Traditional Chinese medicine composition for treating coronary heart disease | |
| CN103550623A (en) | Chinese medicinal composition for treating blood-deficient infertility | |
| CN102247475A (en) | Chinese herb decoction for treating retention of afterbirth of cow and preparation method thereof | |
| CN103405705B (en) | TCM (Traditional Chinese Medicine) oral liquid for breast-feeding pigs | |
| CN103933388B (en) | Traditional Chinese medicinal preparation for treating cyesedema | |
| CN105853782A (en) | Traditional Chinese medicinal composition for treating uterine prolapsed | |
| CN105560994A (en) | Traditional Chinese medicine composition for treating prolapse of uterus | |
| CN101966256B (en) | Medicinal composition for preventing relapse of embryo damage and application thereof | |
| CN104056196A (en) | Traditional Chinese medicine composition for treating bradycardia | |
| CN103191304A (en) | Traditional Chinese medicine composition for treating blood stasis type aplastic anemia |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20111026 Termination date: 20180612 |
|
| CF01 | Termination of patent right due to non-payment of annual fee |